Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective σ1 receptor ligands

被引:36
作者
Huang, YS
Hammond, PS
Whirrett, BR
Kuhner, RJ
Wu, L
Childers, SR
Mach, RH
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Pet Ctr, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
关键词
D O I
10.1021/jm980032l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-(1-benzylpiperidin-4-yl)pherlylacetamide derivatives was synthesized and evaluated for affinity at or and oz receptors. Most of these compounds showed a high affinity for sigma(1) receptors and a low to moderate affinity for sigma(2) receptors. The unsubstituted compound N-(1-benzylpiperidin-4-yl)phenylacetamide, 1, displayed a high affinity and selectivity for sigma(1) receptors (K-i) values of 3.90 nM for sigma(1) receptors and 240 nM for sigma(2) receptors. The influence of substitutions on the phenylacetamide aromatic ring on binding at both the sigma(1) and sigma(2) receptor has been examined through Hansch-type quantitative structure-activity relationship (QSAR) studies. In general, all 3-substituted compounds, except for the OH group, had a higher affinity for both sigma(1) and sigma(2) receptors when compared with the corresponding 2- and 4-substituted analogues. The selectivity for sigma(1) receptors displayed a trend of 3 > 2 approximate to 4 for Cl, Pr, F, NO2, and OMe substituted analogues. Halogen substitution on the aromatic ring generally increased the affinity for sigma(2) receptors while maintaining a similar affinity for sigma(1) receptors. Substitution with electron-donating groups, such as OH, OMe, or NH2, resulted in weak or negligible affinity for sigma(2) receptors and a moderate affinity for sigma(1) receptors. The 2-fluoro-substituted analogue, 11, exhibited the highest selectivity for sigma(1) receptors among all compounds tested, with a K-i value of 3.56 nM for sigma(1) receptors and 667 nM for sigma(2) receptors. Compounds 1, 5, 9, 11, and 20 had no affinity for dopamine D-2 (IC50 > 10 000 nM) and D-3 (IC50 > 10 000 nM) receptors. The nanomolar binding affinity and high selectivity for sigma(1) receptors suggest that these compounds may be developed as potential radiotracers for positron emission tomography or single photon emission computerized tomography imaging studies.
引用
收藏
页码:2361 / 2370
页数:10
相关论文
共 46 条
[1]   REGULATION OF SIGMA-RECEPTORS - HIGH-AFFINITY AND LOW-AFFINITY AGONIST STATES, GTP SHIFTS, AND UP-REGULATION BY RIMCAZOLE AND 1,3-DI(2-TOLYL)GUANIDINE [J].
BEART, PM ;
OSHEA, RD ;
MANALLACK, DT .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (03) :779-788
[2]  
BEM WT, 1991, CANCER RES, V51, P6558
[3]   EVIDENCE FOR A MULTI-SITE MODEL OF THE RAT-BRAIN SIGMA-RECEPTOR [J].
BOWEN, WD ;
HELLEWELL, SB ;
MCGARRY, KA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 163 (2-3) :309-318
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   SIGMA-BINDING SITE LIGANDS INHIBIT CELL-PROLIFERATION IN MAMMARY AND COLON-CARCINOMA CELL-LINES AND MELANOMA-CELLS IN CULTURE [J].
BRENT, PJ ;
PANG, GT .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 278 (02) :151-160
[6]   ENANTIOMERIC N-SUBSTITUTED N-NORMETAZOCINES - A COMPARATIVE-STUDY OF AFFINITIES AT SIGMA, PCP, AND MU OPIOID RECEPTORS [J].
CARROLL, FI ;
ABRAHAM, P ;
PARHAM, K ;
BAI, X ;
ZHANG, X ;
BRINE, GA ;
MASCARELLA, SW ;
MARTIN, BR ;
MAY, EL ;
SAUSS, C ;
DIPAOLO, L ;
WALLACE, P ;
WALKER, JM ;
BOWEN, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2812-2818
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]  
CHIEN CC, 1994, J PHARMACOL EXP THER, V271, P1583
[9]   SIGMA-ANTAGONISTS POTENTIATE OPIOID ANALGESIA IN RATS [J].
CHIEN, CC ;
PASTERNAK, GW .
NEUROSCIENCE LETTERS, 1995, 190 (02) :137-139
[10]   FUNCTIONAL ANTAGONISM OF MORPHINE ANALGESIA BY (+)-PENTAZOCINE - EVIDENCE FOR AN ANTI-OPIOID SIGMA(1) SYSTEM [J].
CHIEN, CC ;
PASTERNAK, GW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) :R7-R8